Intraperitoneal chemotherapy for peritoneal surface malignancy: Experience with 1,000 patients

Journal of the American College of Surgeons

Volumn 218, Issue 4, 2014, Pages 573-585

  Levine, Edward A ^a   Stewart IV, John H ^a   Shen, Perry ^a   Russell, Gregory B ^a   Loggie, Brian L ^b   Votanopoulos, Konstantinos I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; MITOMYCIN; MITOXANTRONE; OXALIPLATIN; SODIUM THIOSULFATE;

ADULT; APPENDIX TUMOR; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ASSESSMENT TOOL; COLORECTAL TUMOR; CYTOREDUCTIVE SURGERY; DRUG DOSE REDUCTION; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVARY TUMOR; OVERALL SURVIVAL; PERITONEUM MESOTHELIOMA; PERSONAL EXPERIENCE; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; STOMA; STOMACH TUMOR; SURVIVAL RATE; SURVIVAL TIME; TRANSFUSION;

ABDOMINAL NEOPLASMS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHILD; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; MULTIVARIATE ANALYSIS; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; PERITONEUM; SURVIVAL ANALYSIS; THIOSULFATES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896490727     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2013.12.013     Document Type: Article

References (83)

1. B. Sadeghi, C. Arvieux, and O. Glehen et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 2000 358 363
2. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
3. M. Torisu, M. Katano, and Y. Kimura et al. New approach to management of malignant ascitis with a streptococcal preparation OK 432: improvement of host immunity and prolongation of survival Surgery 93 1983 357 364
4. S.K. Hendren, S.M. Hahn, and F.R. Spitz et al. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors Ann Surg Oncol 8 2001 65 71
5. W.F. Sindelar, T.F. DeLaney, and Z. Tochner et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study Arch Surg 126 1991 318 324
6. P.H. Sugarbaker, and K.A. Jablonski Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy Ann Surg 221 1995 124 132
7. A.C. Beaujard, O. Glehen, and J.L. Caillot et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis Cancer 88 2000 2512 2519
8. E.A. Levine, J.H. Stewart, and G. Russell et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures J Am Coll Surg 204 2007 943 955
9. V.J. Verwaal, S. van Ruth, and E. de Bree et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 2003 3737 3743
10. D.K. Armstrong, B. Bundy, and L. Wenzel et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 34 43
11. M. Markman, and J.L. Walker Intraperitoneal chemotherapy in ovarian cancer: a review, with a focus on practical aspects of treatment J Clin Oncol 24 2006 988 994
12. T.J. Miner, J. Shia, and D.P. Jaques et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy Ann Surg 241 2005 300 308
13. D.B. Gough, J.H. Donohue, and A.J. Schutt et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach Ann Surg 219 1994 112 119
14. F.L. Hinson, and N.S. Ambrose Pseudomyxoma peritonei Br J Surg 85 1998 1332 1339
15. S.A. Cannistra Intraperitoneal chemotherapy comes of age N Engl J Med 354 2006 77 79
16. J.H. Stewart, P. Shen, and G.B. Russell et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy Ann Surg Oncol 13 2006 1 11
17. R.F. Bradley, J.H. Stewart, and G.B. Russell et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 uniformly treated patients at a single institution, with literature review Am J Surg Pathol 30 2006 551 559
18. P. Shen, E.A. Levine, and J. Hall et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis Arch Surg 138 2003 26 33
19. P. Shen, J. Hawksworth, and J. Lovato et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma Ann Surg Oncol 11 2004 178 186
20. J.J. Hall, B.W. Loggie, and P. Shen et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer J Gastrointest Surg 8 2004 454 463
21. Y. Sun, P. Shen, and J.H. Stewart et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma Am Surg 79 2013 644 648
22. L.S. Krane, A.K. Kader, and E.A. Levine Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma J Surg Oncol 105 2012 258 260
23. R.W. Randle, K. Swett, and P. Shen et al. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis Am Surg 79 2013 620 624
24. A.U. Blackham, P. Shen, and J.H. Stewart et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin vs. cisplatin Ann Surg Oncol 17 2010 2720 2727
25. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
26. R.L. Harmon, and P.H. Sugarbaker Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer Int Semin Surg Oncol 2 2005 3
27. AJCC Cancer Staging Manual 7th ed. 2010 Springer-Verlag New York
28. S. Lentz, B.E. Miller, G.L. Kucera, and E.A. Levine Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma Gynecol Oncol 106 2007 207 210
29. J.H. Stewart, P. Shen, and G.B. Russell et al. A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancer Ann Surg Oncol 15 2008 2137 2145
30. E.A. Levine Problems of success and problems of failure: recurrent disease after cytoreductive surgery and intraperitoneal chemoperfusion Ann Surg Oncol 11 2004 351 353
31. R.L. Dedrick, and M.F. Flessner Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure J Natl Cancer Inst 89 1997 480 487
32. R.L. Dedrick Interspecies scaling of regional drug delivery J Pharm Sci 75 1986 1047 1052
33. M.F. Flessner, R.L. Dedrick, and J.S. Schultz A distributed model of peritoneal-plasma transport: analysis of experimental data in the rat Am J Physiol 248 1985 F413 F424
34. T. Kuzuya, M. Yamauchi, and A. Ito et al. Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy J Pharm Pharmacol 46 1994 685 689
35. J.L. Speyer, J.M. Collins, and R.L. Dedrick et al. Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally Cancer Res 40 1980 567 572
36. V.K. Israel, C. Jiang, and F.M. Muggia et al. Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study Cancer Chemother Pharmacol 37 1995 32 38
37. R.F. Ozols, R.C. Young, and J.L. Speyer et al. Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer Cancer Res 42 1982 4265 4269
38. D.L. Bartlett, J.F. Buell, and S.K. Libutti et al. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis Cancer 83 1998 1251 1261
39. M. Markman, and D. Kelsen Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma J Cancer Res Clin Oncol 118 1992 547 550
40. M. Markman, M.F. Brady, and N.M. Spirtos et al. Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study J Clin Oncol 16 1998 2620 2624
41. E. Dikomey, and J. Franzke Effect of heat on induction and repair of DNA strand breaks in X-irradiated CHO cells Int J Radiat Biol 61 1992 221 233
42. J.L. Roti, H.H. Kampinga, and R.S. Malyapa et al. Nuclear matrix as a target for hyperthermic killing of cancer cells Cell Stress Chaperones 3 1998 245 255
43. B. Barlogie, P.M. Corry, and B. Drewinko In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C Cancer Res 40 1980 1165 1168
44. P. Jacquet, A. Averbach, and O.A. Stuart et al. Hyperthermic intraperitoneal doxorubicin:pharmacokinetics, metabolism and tissue distribution in a rat model Cancer Chemother Pharmacol 41 1998 147 154
45. G. Los, O.A.G. Smals, and M.J.H. van Vugt et al. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity Cancer Res 52 1992 1252 1258
46. J.F. Shapiro, J.L. Chase, and R.A. Wolff et al. Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin Cancer 116 2010 316 322
47. S. van Ruth, Y.I. Acherman, and M.J. van de Vijver et al. Pseudomyxoma peritonei: a review of 62 cases Eur J Surg Oncol 29 2003 682 688
48. O. Glehen, F. Mohamed, and F.N. Gilly Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia Lancet Oncol 5 2004 219 228
49. E.A. Levine, D.G. Blazer, and M.K. Kim et al. Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes J Am Coll Surg 214 2012 599 607
50. P.H. Sugarbaker, and D. Chang Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 1999 727 731
51. A.J. Witkamp, E. de Bree, and M.M. Kaag et al. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei Br J Surg 88 2001 458 463
52. T.C. Chua, B.J. Moran, and P.H. Sugarbaker et al. Early and long-term outcome data on 2298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy J Clin Oncol 30 2012 2449 2456
53. M. Deraco, D. Baratti, and M.G. Inglese et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Ann Surg Oncol 11 2004 393 398
54. S. Shetty, B. Natarajan, and P. Thomas et al. Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival Am Surg 79 2013 1171 1176
55. B.M. Ronnett, C.M. Zahn, and R.J. Kurman et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei" Am J Surg Pathol 19 1995 1390 1408
56. C.U. Ihemelandu, R. McQuellon, and P. Shen et al. Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS + HIPEC) with preoperative FACT-C (functional assessment of cancer therapy) and patient rated performance status Ann Surg Oncol 20 2013 3519 3526
57. A.T. Culliford, A.D. Brooks, and S. Sharma et al. Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer Ann Surg Oncol 8 2001 787 795
58. E.A. Marcus, T.K. Weber, and M.A. Rodriguez-Bigas et al. Prognostic factors affecting survival in patients with colorectal carcinomatosis Cancer Invest 17 1999 249 252
59. M.L. Rothenberg, A.M. Oza, and R.H. Bigelow et al. Superiority of oxaliplatin and fluorouracil-leukovorin as first-line treatment of metastatic colorectal cancer J Clin Oncol 21 2003 2059 2069
60. H. Hurwitz, L. Fehrenbacher, and W. Novotny et al. Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
61. J. Franko, Q. Shi, and C.D. Goldman et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841 J Clin Oncol 30 2012 263 267
62. T. Yan, D. Black, R. Savady, and P.H. Sugarbaker Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma J Clin Oncol 24 2006 4011 4019
63. O. Glehen, F. Kwiakowski, and P.H. Sugarbaker et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 2004 3284 3292
64. J. Franko, Z. Ibrahim, and N.J. Gusani et al. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis Cancer 116 2010 3756 3762
65. K. Turaga, E.A. Levine, and R. Barone et al. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States Ann Surg Oncol 2013 Jun 21 [Epub ahead of print]
66. W.S. Robinson, and R.A. Lake Advances in malignant mesothelioma N Engl J Med 353 2005 1591 1603
67. J.K. Trupiano, K.M. Geisinger, and M.D. Willingham et al. Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers Mod Pathol 17 2004 476 481
68. A.L. Feldman, S.K. Libutti, and J.F. Pingpank et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy J Clin Oncol 21 2003 4560 4567
69. B.J. Park, R. Alexander, and S.K. Lubutti et al. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion Ann Surg Oncol 6 1999 582 590
70. C.A. Cerruto, E.A. Brun, D. Chang, and P.H. Sugarbaker Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma Arch Pathol Lab Med 130 2006 1654 1661
71. C. Cao, T.D. Yan, and M. Deraco et al. Importance of gender in diffuse malignant peritoneal mesothelioma Ann Oncol 23 2012 1494 1498
72. T.C. Chua, T.D. Yan, and M. Deraco et al. Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma Br J Surg 98 2011 60 64
73. T.D. Yan, M. Deraco, and D. Barratti et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience J Clin Oncol 27 2009 6237 6242
74. T.D. Yan, M. Deraco, and D. Elias et al. A novel tumor node metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma based on outcome analysis of a multi-institutional database Cancer 117 2011 1855 1863
75. R.P. McQuellon, B.W. Loggie, and R.A. Fleming et al. Quality of life after intraperitoneal hyperthermic chemotherapy (HIPEC) for peritoneal carcinomatosis Eur J Surg Oncol 27 2001 65 73
76. R.P. McQuellon, B.W. Loggie, and A.B. Lehman et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis Ann Surg Oncol 10 2003 155 162
77. K.E. Duckworth, R.P. McQuellon, and G.B. Russell et al. Patient reported outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS+HIPEC) J Surg Oncol 106 2012 376 380
78. Alexander HR, Mavroukakis SM, Libutti SK, et al. Impact of tumor resection and intraperitoneal chemotherapy on health related quality of life in patients with peritoneal surface malignancies. Proceedings of the 57th Annual Society of Surgical Oncology Cancer Symposium. 2004.
79. A.G. Portilla, P.H. Sugarbaker, and D. Chang Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features World J Surg 23 1999 23 29
80. K. Votanopoulos, C. Ihemelandu, and P. Shen et al. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy; it is all about selection and tumor biology J Am Coll Surg 215 2012 412 417
81. R. Hoverman, T.H. Cartwright, and D.A. Patt et al. Pathways, outcomes and costs in colon cancer: retrospective evaluations in two distinct databases J Oncol Pract 7 2011 52s 59s
82. D. Lawrence, M. Maschio, and K.J. Leahy et al. Economic analysis of bevacizumab, cetuximab, panitumumab, with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC) J Med Econ 16 2013 1387 1398
83. D. Elias, J.R. Delperro, and L. Sideris et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials Ann Surg Oncol 11 2004 518 521